OnKure Therapeutics, Inc. OKUR Proceeds from issuance of common stock relating to employee stock plans
Proceeds from issuance of common stock relating to employee stock plans at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s proceeds from issuance of common stock relating to employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s proceeds from issuance of common stock relating to employee stock plans?
- OnKure Therapeutics, Inc. (OKUR) reported proceeds from issuance of common stock relating to employee stock plans of $60K in Q4 2025.